Title : Lenvatinib: first global approval.

Pub. Date : 2015 Apr

PMID : 25795101






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lenvatinib (Lenvima ) is a multitargeted receptor kinase inhibitor that inhibits the kinase activities of vascular endothelial-derived growth factor receptors 1, 2 and 3, fibroblast growth factor receptors 1, 2, 3 and 4, platelet-derived growth factor receptor alpha, RET and KIT. lenvatinib platelet derived growth factor receptor alpha Homo sapiens
2 Lenvatinib (Lenvima ) is a multitargeted receptor kinase inhibitor that inhibits the kinase activities of vascular endothelial-derived growth factor receptors 1, 2 and 3, fibroblast growth factor receptors 1, 2, 3 and 4, platelet-derived growth factor receptor alpha, RET and KIT. lenvatinib platelet derived growth factor receptor alpha Homo sapiens